Transactivation of Sphingosine-1–Phosphate Receptors by FcɛRI Triggering Is Required for Normal Mast Cell Degranulation and Chemotaxis by Jolly, Puneet S. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
The Journal of Experimental Medicine • Volume 199, Number 7, April 5, 2004 959–970
http://www.jem.org/cgi/doi/10.1084/jem.20030680
 
959
 
Transactivation of Sphingosine-1–Phosphate Receptors by 
Fc
 
 
 
RI Triggering Is Required for Normal Mast Cell 
Degranulation and Chemotaxis
 
Puneet S. Jolly,
 
1,2
 
 Meryem Bektas,
 
1
 
 Ana Olivera,
 
3
 
 Claudia Gonzalez-Espinosa,
 
3
 
 
 
Richard L. Proia,
 
4
 
 Juan Rivera,
 
3
 
 Sheldon Milstien,
 
5
 
 and Sarah Spiegel
 
1
 
1
 
Department of Biochemistry, Virginia Commonwealth University Medical Center, Richmond, VA 23298
 
2
 
Department of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20007
 
3
 
National Institute of Arthritis and Musculoskeletal and Skin Diseases, 
 
4
 
National Institute of Diabetes and Digestive 
and Kidney Diseases, and 
 
5
 
National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892
 
Abstract
 
Mast cells secrete various substances that initiate and perpetuate allergic responses. Cross-linking
of the high-affinity receptor for IgE (Fc
 
 
 
RI) in RBL-2H3 and bone marrow–derived mast
cells activates sphingosine kinase (SphK), which leads to generation and secretion of the potent
sphingolipid mediator, sphingosine-1–phosphate (S1P). In turn, S1P activates its receptors S1P
 
1
 
and S1P
 
2
 
 that are present in mast cells. Moreover, inhibition of SphK blocks Fc
 
 
 
RI-mediated
internalization of these receptors and markedly reduces degranulation and chemotaxis. Although
transactivation of S1P
 
1
 
 and Gi signaling are important for cytoskeletal rearrangements and
migration of mast cells toward antigen, they are dispensable for Fc
 
 
 
RI-triggered degranulation.
However, S1P
 
2
 
, whose expression is up-regulated by Fc
 
 
 
RI cross-linking, was required for
degranulation and inhibited migration toward antigen. Together, our results suggest that activation
of SphKs and consequently S1PRs by Fc
 
 
 
RI triggering plays a crucial role in mast cell functions
and might be involved in the movement of mast cells to sites of inflammation.
Key words: sphingosine kinase • S1P receptors • RBL-2H3 cells • motility
 
Introduction
 
Mast cells play pivotal roles in immediate-type and
inflammatory allergic reactions that can result in
asthma.  Cross-linking of the high-affinity receptor for
IgE (Fc
 
 
 
RI) on these cells activates signaling pathways
that lead to degranulation and the release of histamine and
other preformed mediators, as well as de novo synthesis of
the arachidonic acid metabolites, leukotrienes, and prosta-
glandins. Infiltration of airway smooth muscle by mast
cells is associated with the disordered airway function
found in asthma (1). Although mast cells also synthesize
and release several proinflammatory cytokines and chemo-
kines capable of recruiting eosinophils, monocytes, and T
cells, it is not well understood how mast cells themselves
are recruited.
An addition to the recognized repertoire of Fc
 
 
 
RI-
mediated signaling events is the activation of sphingosine
kinase (SphK), which results in conversion of sphingosine
to the novel sphingolipid mediator, sphingosine-1–phosphate
(S1P; references 2–4). In rat basophilic leukemia RBL-2H3
cells, Fc
 
 
 
RI cross-linking leads to activation of SphK and
formation of S1P, which acts as a second messenger to
mobilize calcium from intracellular stores by an InsP
 
3
 
-
independent pathway (2). Similarly, in human bone marrow–
derived mast cells (BMMCs), aggregation of Fc
 
 
 
RI resulted
in activation of phospholipase D, leading to activation of
SphK1, which mediated rapid calcium release from intra-
cellular stores (5).
Recently, the intracellular actions of S1P have been a
matter of great debate due to the discovery that S1P is a
ligand for a family of five specific G protein–coupled receptors
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N
 
,
 
N
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essential medium; Fc
 
 
 
RI, high-affinity receptor for IgE; GPCR, G protein–
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(GPCRs) known as S1P
 
1–5
 
 (6). These S1PRs are differen-
tially expressed and coupled to a variety of G proteins;
they regulate diverse signaling pathways. In particular,
S1PRs have been shown to play critical roles in cell migra-
tion (6). S1P
 
1
 
 is essential for lymphocyte trafficking and
regulates egress from thymus and peripheral lymphoid
organs (7).
We showed previously that S1P levels were significantly
increased in bronchoalveolar lavage fluid from the lungs of
asthmatics after challenge with an allergen (8) and, thus, it
was of importance to examine the role of S1P formation
and its receptors in mast cell function. Although expression
of the S1P receptors, S1P
 
1–4
 
, has been detected in dendritic
cells (9), to date, their expression in mast cells has not been
reported, and previous studies with mast cells were not fo-
cused on the likely possibility of S1P receptor–mediated
functions. In this paper, we show that Fc
 
 
 
RI triggering ac-
tivates SphK type 1 in mast cells resulting in S1P secretion.
In turn, S1P transactivates the cell surface receptors, S1P
 
1
 
and S1P
 
2
 
, to modulate mast cell functions, such as migra-
tion toward antigen and degranulation, which are impor-
tant for asthmatic and allergic responses.
 
Materials and Methods
 
Mast Cell Culture. 
 
BMMCs were isolated from 8-wk-old
SV129 
 
 
 
 C57/bl6 wild-type and gene-disrupted mice and cul-
tured as described previously (10). RBL-2H3 cells (CRL-2256;
American Type Culture Collection) were grown as monolayer
cultures in Eagle’s minimal essential medium (EMEM; Biofluids)
supplemented with 15% heat-inactivated FBS.
BMMCs were sensitized for 3 h with 1 
 
 
 
g/ml anti-DNP IgE
in complete EMEM media without IL-3. RBL-2H3 cells were
similarly sensitized for 12 h. Cells were washed and stimulated
with 40 ng/ml or 100 ng/ml DNP-HSA (Ag) for BMMCs and
RBL-2H3 cells, respectively, or with 100 nM S1P unless speci-
fied otherwise.
 
Measurement of S1P. 
 
Lipids were extracted from 5 
 
 
 
 10
 
6
 
RBL-2H3 cells, and supernatants and mass levels of S1P were de-
termined as described previously (11).
 
SphK Assay. 
 
SphK1 and SphK2 activities were measured as
described previously (reference 12 and Supplemental Materials
and Methods, available at http://www.jem.org/cgi/content/full/
jem.20030680/DC1).
 
Degranulation and Chemotaxis. 
 
Degranulation of 10
 
6 
 
mast
cells was measured by assaying 
 
 
 
-hexosaminidase release as de-
scribed previously (13). Net degranulation is expressed as the per-
centage of total cellular 
 
 
 
-hexosaminidase released to the me-
dium after antigen stimulation minus that released spontaneously.
Spontaneous release was always 
 
 
 
5%. Chemotaxis was measured
in a modified Boyden chamber using polycarbonate filters (25 
 
 
 
80 mm, 8-
 
 
 
M pore size). Chemoattractants were added to the
lower chamber, and 5 
 
 
 
 10
 
4
 
 cells were added to the upper cham-
ber. After 3 h, unless indicated otherwise, migrated cells were
counted as described previously (14). Each data point is the aver-
age number of cells in four random fields (each counted twice)
and is the mean 
 
 
 
 SD of three individual wells.
 
RT-PCR and Ribonuclease Protection Assays (RPAs). 
 
Total
RNA was isolated from BMMCs and RBL-2H3 cells with TRI-
zol Reagent (Life Technologies) and digested with DNase (Pro-
mega). RNA was reverse transcribed with Superscript II (Life
Technologies). Sequences of oligonucleotide primers are pro-
vided in Table S1 (available at http://www.jem.org/cgi/content/
full/jem.20030680/DC1).
For RPA, custom-made probe sets for mast cell lymphokines
(50 ng) were labeled using the RiboQuant™ In Vitro Transcrip-
tion Kit and hybridized with 10 
 
 
 
g RNA from 2 
 
 
 
 10
 
6 
 
BMMCs
using reagents provided in the RiboQuant™ RPA Kit (BD Bio-
sciences) as described previously (13).
 
Transfection. 
 
RBL-2H3 cells were electroporated with a
Gene Pulser (BioRad Laboratories) at 250 mV and 500 
 
 
 
F using
25 
 
 
 
g DNA and 200,000 cells/
 
 
 
l in EMEM supplemented with
15% FBS and 50 mM Hepes, pH 7.4. For transient expression,
cells were allowed to recover for 24 h. For stable expression, cells
were allowed to recover for 24 h. Cells expressing green fluores-
cent protein (GFP) were sorted with an argon dual laser flow cy-
tometer (model 753; EPICS) and cultured in the presence of 1
mg/ml G418.
S1P
 
2
 
 cDNA was cloned from RBL-2H3 cells by PCR using
the following primers: forward, 5
 
 
 
-CCCACCATGGGCGGTT-
TATACTCAGAG-3
 
 
 
; and reverse, 5
 
 
 
-CCACTGTGTTGC-
CCTCCAGAAATGTTG-3
 
 
 
. S1P
 
1
 
, S1P
 
2
 
, and SphK1 cDNAs
were also cloned into pcDNA3.1-GFP for expression of the GFP
fusion proteins.
SphK1 expression was down-regulated with sequence-specific
small interfering (si) RNA. siRNA for rat SphK1, 5
 
 
 
-CUGG-
CCUACCUUCCUGUAGdTT-3
 
 
 
 and 5
 
 
 
-CUACAGGAAG-
GUAGGCCAGdTT-3
 
 
 
; rat SphK2, 5
 
 
 
-GCUGGGCUGUCCU-
UCAACCUdTT-3
 
 
 
 and 5
 
 
 
-AGGUUGAAGGACAGCCCAG-
CdTT-3
 
 
 
; and control siRNA were synthesized at QIAGEN. 7 
 
 
 
10
 
5
 
 cells were transfected in six-well dishes for 3 h with the 21-
nucleotide duplexes using Oligofectamine (Invitrogen) as recom-
mended by the manufacturer.
Expression of S1P
 
1
 
 and S1P
 
2
 
 were down-regulated by transfection
with 18-mer phosphothioate oligonucleotides as described previ-
ously (15, 16). In brief, antisense S1P
 
1
 
, 5
 
 
 
-GACGCTGGTGGGC-
CCCAT-3
 
 
 
; sense S1P
 
1
 
, 5
 
 
 
-ATGGGGCCCACCAGCGTC-3
 
 
 
;
scrambled S1P
 
1
 
, 5
 
 
 
-TGATCCTTGGCGGGGCCG-3
 
 
 
; antisense
S1P
 
2
 
, 5
 
 
 
-CGAGTACAAGCTGCCCAT-3
 
 
 
; sense S1P
 
2
 
, 5
 
 
 
-
ATGGGCAGCTTGTACTCG-3
 
 
 
; and scrambled S1P
 
2
 
, 5
 
 
 
-ACG-
TAGGGCTTGCCATTG-3
 
 
 
 were synthesized by Integrated DNA
Technologies. 7 
 
 
 
 10
 
5
 
 cells were transfected with oligos at a final
concentration of 1 
 
 
 
M in six-well dishes using Oligofectamine.
 
Measurement of MCP-1 and MIP1
 
 
 
. 
 
Secretion of monocyte
chemoattractant protein 1 (MCP-1) and macrophage inflamma-
tory protein 1 (MIP1) 
 
 
 
 into the medium upon Ag challenge of
2 
 
 
 
 10
 
7
 
 IgE-sensitized BMMCs was determined as described
previously (13).
 
Confocal Microscopy. 
 
RBL-2H3 cells were treated as de-
scribed in figure legends, fixed in 3% formaldehyde, and visual-
ized by confocal fluorescence microscopy (LSM model 510; Carl
Zeiss MicroImaging, Inc.) with a 60
 
 
 
 oil immersion objective
(Supplemental Materials and Methods).
 
Statistical Analysis. 
 
Experiments were repeated at least three
times with consistent results. Statistics were performed using Sig-
maStat 2.0. Differences between groups were determined with the
paired Student’s 
 
t
 
 test, or a one-way analysis of variance (ANOVA)
with a Tukey post-Hoc; P 
 
 
 
 0.05 was considered significant.
 
Online Supplemental Material. 
 
For details regarding antibod-
ies, Western blotting, confocal microscopy, immunohistochemis-
try, and S1P and SphK determinations, see the Supplemental Ma-
terials and Methods. Table S1 shows the sequences of the primers
used for RT-PCR. Fig. S1 demonstrates that S1P induces inter- 
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nalization of S1P
 
1
 
 and reorganization of the actin cytoskeleton.
Fig. S2 depicts translocation of GFP-SphK1 to the plasma mem-
brane after Fc
 
 
 
RI cross-linking, in contrast to GFP-SphK2 or
GFP-vector. Fig. S3 demonstrates that IgE triggering activates
SphK1 but not SphK2. Fig. S4 shows that Fc
 
 
 
RI cross-linking–
induced internalization of S1P
 
1
 
 requires SphK. Online supple-
mental material is available at http://www.jem.org/cgi/content/
full/jem.20030680/DC1.
Results
Fc RI Cross-linking Induces S1P Formation and Release from
Mast Cells. In agreement with previous papers (2, 4),
Fc RI cross-linking rapidly increased SphK activity in both
BMMCs and RBL-2H3 cells (Fig. 1, A and B). Consistent
with the increased SphK activity measured in vitro, there
was a concomitant rapid increase in intracellular levels of
S1P that began to plateau within 10 min (Fig. 1 C). Direct
mass measurements revealed that stimulated mast cells also
secreted S1P into the medium. Significant secretion was de-
tectable within 2 min and gradually increased after Fc RI
cross-linking (Fig. 1 C). These results are in agreement with
a previous analysis showing that allergically activated CPII
and BMMCs also release S1P into the supernatant (4). Im-
portantly, IgE/Ag-activated RBL-2H3 cells do not secrete
detectable levels of sphingosine, suggesting that the secreted
S1P is indeed formed intracellularly and not extracellularly
as has been suggested for other cell types (17).
Expression of SphKs and S1PRs in Mast Cells. Recently,
two distinct isoforms of SphK, designated SphK1 and
SphK2, have been cloned and characterized (12, 18). Al-
though human BMMCs have been reported to express only
SphK1 (5), murine BMMCs and RBL-2H3 cells express
both SphK1 and SphK2 (Fig. 1 D). There were no signifi-
cant changes in their mRNA expressions after Fc RI cross-
linking, supporting the notion that SphK activity is in-
creased by posttranslational events.
Previous papers demonstrated that Fc RI cross-linking
leads to activation of SphK and formation of S1P, which
acts intracellularly to mobilize calcium from intracellular
stores by an InsP3-independent pathway (2, 5). However,
the best characterized actions of S1P are as an extracellular
ligand for the S1PRs (6). Although the five S1PRs are
ubiquitously expressed, their expression in mast cells has
not been examined previously. RT-PCR analysis of un-
treated BMMCs and RBL-2H3 cells revealed that S1P1 and
S1P2 were expressed (Fig. 1 D), but not S1P3, S1P4, or
S1P5 (unpublished data). Interestingly, S1P2 expression in
both BMMCs and RBL-2H3 cells was increased after
Fc RI cross-linking (Fig. 1 D). The presence of S1P1 and
S1P2 proteins was also examined with specific antibodies in
Figure 1. Fc RI cross-linking
stimulates SphK and increases
S1P. BMMCs (A) and RBL-2H3
cells (B and C) were sensitized
with anti-DNP IgE and treated
with DNP-HSA as described in
Materials and Methods. At the
indicated times, cells were lysed,
and SphK activity was measured
in the presence of 0.25% Triton
X-100. Data are presented as fold
increase   SD. SphK activity in
unstimulated BMMCs and RBL-
2H3 cells were 1.5   0.4 and
3.4   0.4 pmol/min/mg, respec-
tively. *, P   0.05 by Student’s t
test. (C) Mast cells secrete S1P.
RBL-2H3 cells were sensitized
with anti-DNP IgE, washed, and
treated with DNP-HSA in serum-
free medium containing 4 mg/ml
BSA. Mass levels of S1P in
RBL-2H3 cells (closed symbols)
and media (open symbols) were
measured at the indicated times.
*, P   0.05 by Student’s t test.
(D and E) Expression of SphKs
and S1PRs in mast cells. (D) RT-
PCR analysis of expression of
SphKs and S1PRs. Anti-DNP
IgE-sensitized BMMCs and RBL-
2H3 cells were stimulated with-
out or with DNP-HSA (Ag).
After 1 h at 37 C, RNA was
extracted and SphKs, S1PRs, and glyceraldehyde-3–phosphate dehydrogenase (GAPDH) mRNAs were determined by RT-PCR. No PCR products
were detected in the absence of RT. (E) IgE-sensitized RBL-2H3 cells were treated with Ag for the indicated times, and cell lysates were examined by
Western blotting with anti-S1P2 or anti-S1P1 (Exalpha) and subsequently with antitubulin antibody to show equal loading as described in Supplemental
Materials and Methods.Transactivation of Mast Cell S1PRs by Fc RI 962
crude membrane fractions of RBL-2H3 cells (Fig. 1 E). In
agreement with mRNA analysis, levels of S1P2 but not
S1P1 were increased after cross-linking of Fc RI with Ag
(Fig. 1 E).
The Role of S1P in Mast Cell Chemokine and Cytokine Ex-
pression. Activated mast cells produce and secrete cyto-
kines and chemokines capable of modulating immune re-
sponses (19). S1P stimulated leukotriene synthesis in CPII
mast cells (4) and induced release of Th2 cytokines from
mature dendritic cells (9). Because RBL-2H3 cells secrete
S1P, we examined its effects on cytokine and chemokine
mRNA expression profiles. S1P had no significant effects
on cytokines (Fig. 2 A), yet it markedly increased expres-
sion of the chemokines (Fig. 2 B), although much less
potently than IgE/Ag. Expression of MCP-1, MIP1- ,
MIP1- , MIP2 (belonging to the CC-chemokine family),
and MIF, all important modulators of monocyte and eo-
sinophil recruitment and inflammation, were significantly
increased by S1P. In agreement with the RPA profile, se-
cretion of both MIP-1  (Fig. 2 C) and MCP-1 (Fig. 2 D)
determined by ELISA was significantly increased by S1P,
albeit less potently than IgE/Ag.
S1P Stimulates Migration of Mast Cells. Because S1P in-
duces chemotaxis of many types of cells (6), it was of inter-
est to determine whether movement of mast cells is also
regulated by S1P. Using a modified Boyden chamber assay,
we found that chemotaxis of RBL-2H3 cells was markedly
stimulated by S1P, even at concentrations as low as 1 nM
and showed a maximum response at a concentration of 10
nM (Fig. 2 E). These extremely low concentrations of S1P
suggest the involvement of a S1PR. Moreover, pertussis
toxin (PTX) ablated migration toward S1P, implicating a
Gi-dependent pathway. Yet, as expected, migration toward
fibronectin was not altered by PTX. To confirm that S1P-
induced migration was mediated by binding to S1PRs, we
used the S1P mimetic sphinganine-1–phosphate (dihydro-
S1P), which has no known intracellular effects, but is able
to bind to and signal through all of the S1PRs (6). RBL-
2H3 cells migrated toward dihydro-S1P with very similar
concentration-dependent effects as S1P (Fig. 2 F).
Cell migration is a complex process involving reorgani-
zation of the actin cytoskeleton and formation of lamellipo-
dia and/or filopodia at the leading edge. Because S1P1 is
emerging as a critical component of migratory responses to
S1P (6), we examined its role in mast cell cytoskeleton re-
arrangements. As with other GPCRs, GFP tagging of
S1PRs has been extensively used to study receptor inter-
nalization after activation (6, 20). Moreover, we found pre-
viously that S1P1-GFP transduces intracellular signals in a
manner indistinguishable from that of the wild-type recep-
tor (20). S1P1-GFP was expressed mainly on the plasma
membrane of RBL-2H3 cells with minimal membrane ruf-
fling, and F-actin was localized to the cell cortex (Fig.
S1 A, available at http://www.jem.org/cgi/content/full/
jem.20030680/DC1). As expected, addition of S1P caused
internalization of S1P1-GFP (Fig. S1 B). In addition, S1P
induced dramatic remodeling of the actin cytoskeleton
such that the cortical actin redistributed in protrusion-like
Figure 2. S1P increases synthe-
sis of proinflammatory chemo-
kines.  BMMCs were treated
without (None) or with 100 nM
S1P or IgE/Ag for 1 h, and total
RNA was extracted. mRNA
expression of the indicated cyto-
kines (A) or chemokines (B), and
L32 and GAPDH controls were
determined by RPA. (C and D)
BMMCs were stimulated with
S1P or IgE/Ag for 4 h, and the
secretion of MIP-1  (C) and
MCP-1 (D) was measured by
ELISA. *, P   0.001 by Student’s
t test. (E and F) Chemotaxis of
mast cells toward S1P. RBL-
2H3 cells were allowed to migrate
toward 20  g/ml fibronectin (FN)
or the indicated concentrations of
S1P (E) or dihydro-S1P (F) for
2 h. Where indicated, cells were
pretreated for 12 h with 200
ng/ml pertussis toxin (PTX).
The data are mean   SD of three
individual wells. *, P   0.05 by
Student’s t test. #, P   0.05 by
ANOVA. NS, not significant.
Note that PTX had no effect on
chemotaxis toward fibronectin.Jolly et al. 963
structures reminiscent of lamellipodia, which were promi-
nent in S1P1-transfected cells (Fig. S1 B).
Fc RI Cross-linking Stimulates and Translocates SphK1,
Not SphK2. Previous studies with human BMMCs have
shown that SphK1 is primarily cytosolic and is rapidly trans-
located to the plasma membrane after aggregation of Fc RI
(5). In agreement, confocal microscopy revealed that GFP-
SphK1 is diffusely distributed in the cytosol of unstimulated
RBL-2H3 cells and Fc RI cross-linking induced its trans-
location within 1 min from the cytosol to the plasma
membranes where its substrate sphingosine resides (Fig.
S2 A, available at http://www.jem.org/cgi/content/full/
jem.20030680/DC1). Similarly, by immunoblotting analy-
sis, GFP-SphK1 was expressed predominantly in the cytosol
and was rapidly translocated to membrane fractions upon
aggregation of Fc RI (Fig. S2 B). In contrast, no transloca-
tion of GFP vector or GFP-SphK2 to the plasma membrane
was detected (Fig. S2). Because mast cells express both
SphK1 and SphK2 (Fig. 1 D), it was of interest to determine
which of the endogenous isoforms is being activated by IgE
cross-linking. SphK1 can be distinguished from SphK2 on
the basis of differential activity measured when the substrate
sphingosine is added as a BSA complex in the presence of
high salt or in a micellar form with Triton X-100 (12). Al-
though Triton X-100 stimulates SphK1 and strongly inhib-
its SphK2, high salt is optimal for SphK2 and drastically in-
hibits SphK1 (12, 21). IgE/Ag induced  10-fold increase
in membrane-associated SphK activity measured in the
presence of Triton X-100 (Fig. S3 A, available at http://
www.jem.org/cgi/content/full/jem.20030680/DC1), which
was not evident when the activity was measured in the pres-
ence of high salt without Triton (Fig. S3 B), suggesting that
only SphK1 is activated by IgE triggering. To further con-
firm this notion, we examined the effect of Fc RI cross-
linking on RBL-2H3 cells transfected with SphK1 and
SphK2. Overexpression of SphK1 increased SphK activity
from 6   2 to 568   32 pmol/min/mg ( 100-fold),
whereas overexpression of SphK2 only increased activity to
100   10 pmol/min/mg ( 15-fold), in agreement with
previous observations that high levels of SphK2 are detri-
mental (22). IgE/Ag markedly activated overexpressed
SphK1 by more than fivefold but did not stimulate overex-
pressed SphK2 (Fig. S3, C and D). Together, these results
suggest that Fc RI triggering activates and translocates
SphK1 to mast cell membranes resulting in increased forma-
tion and subsequent secretion of S1P.
Figure 3. Fc RI cross-linking–induced internalization of S1P1 and S1P2.
RBL-2H3 cells transfected with S1P2-GFP (A) were treated with 100 nM S1P or
sensitized with IgE and treated with 100 ng/ml DNP-HSA (Ag) for the indicated
times, fixed, and examined by confocal fluorescence microscopy as described in
Supplemental Materials and Methods. Where indicated, cells were pretreated
with 10  M DMS for 20 min before addition of Ag. Representative cells from
 100 examined. (B) Translocation of  -arrestin. RBL-2H3 cells stably expressing S1P1 or vector were transfected with  -arrestin2–YFP and plated on
glass coverslips. The next day, cells were serum starved for 12 h and treated for 5 min with Ag. YFP fluorescence was visualized by confocal microscopy
with the 514 nm argon laser. (C) Internalization of endogenous S1P1 by S1P and Fc RI cross-linking. RBL-2H3 cells were treated with vehicle, 100 nM
S1P, or 100 ng/ml DNP-HSA (Ag) for 60 min, fixed, incubated with S1P1 antibody (1:100), and examined by confocal microscopy after staining with
Cy2-conjugated secondary antibody. Representative results from  30 cells were examined. No fluorescence was detected when the primary antibody was
omitted, when the S1P1 antibody was preincubated with the peptide antigen, or in the absence of S1P1 expression.Transactivation of Mast Cell S1PRs by Fc RI 964
Fc RI Cross-linking Transactivates S1P1 and S1P2. As
S1P is secreted by mast cells upon Fc RI cross-linking, it
was important to determine whether this S1P could in turn
activate S1PRs. S1P, like other ligands for GPCRs, induces
internalization of S1PRs upon ligation and activation (Fig.
S1 D). S1P2 similar to S1P1 is localized on the cell surface of
unstimulated RBL-2H3 cells transfected with GFP fusion
proteins (Fig. 3 A). Remarkably, IgE/Ag induced internal-
ization of both S1P1 and S1P2 similar to exogenous S1P
(Fig. 3 A and Fig. S4, available at http://www.jem.org/cgi/
content/full/jem.20030680/DC1).  -Arrestins are cytosolic
adaptor proteins that bind with high affinity to agonist-acti-
vated, phosphorylated GPCRs, and their translocation to
plasma membranes has been used to examine activation of
various overexpressed receptors (23), including S1P1 (16).
In agreement with the observation of S1PR internalization,
Fc RI cross-linking promoted rapid redistribution of
 -arrestin2 tagged with yellow fluorescent protein (YFP)
from the cytoplasm to the plasma membrane only in S1P1-
expressing RBL-2H3 cells (Fig. 3 B). The lack of such
translocation in vector-transfected cells (Fig. 3 B) suggests
that expression of S1P1 was required for this translocation
and excludes the possibility that  -arrestin2 recruitment
to the plasma membrane was caused by activation of unre-
lated GPCRs. These results further support the notion
that IgE cross-linking stimulates production of the ligand
for S1P1.
To confirm that internalization of S1P1 and S1P2 in-
duced by Fc RI triggering was due to activation of SphK
and the release of newly generated S1P, mast cells were
pretreated with the specific SphK inhibitor N,N-dimethyl-
sphingosine (DMS). DMS almost completely prevented in-
ternalization of S1P1 or S1P2 induced by Fc RI cross-link-
ing, but not by S1P (Fig. 3 A and Fig. S4), indicating that
activation of SphK and production of S1P is a necessary
event in transactivation of these S1PRs.
Although epitope-tagged S1P1 has been used extensively
to study internalization and signaling upon ligation of S1P
(20, 24) and functions in an analogous manner as the en-
dogenous receptor (20), overexpression may not exactly
reproduce the physiological distribution of endogenous re-
ceptors. Thus, we examined next whether endogenous
S1P1 is also activated by its ligand produced by IgE/Ag
triggering. In untreated cells, endogenous S1P1, visualized
with a specific antibody, was prominently localized on the
plasma membrane, as expected of unstimulated GPCRs,
and internalized after treatment with exogenous S1P (Fig. 3
C). Moreover, Fc RI aggregation also induced internaliza-
tion of the endogenously expressed S1P1. Collectively,
these results suggest that IgE triggering stimulates produc-
tion of S1P, which transactivates S1P1 on the cell surface.
S1P2 Is Critical for IgE/Ag-induced Degranulation. In
agreement with a previous paper demonstrating that S1P
induced degranulation of CPII mast cells (4), we found that
S1P induces degranulation of BMMCs as determined by
 -hexosaminidase release, albeit to a lesser extent than IgE/
Ag (Fig. 4 A). It was of interest to investigate the possibility
that S1P generated in response to IgE triggering might
contribute to mast cell activation. To this end, we used
DMS, which effectively inhibits SphK1 (18) and SphK2
(12) and has no effect on protein kinase C (25) or other sig-
naling pathways (26). Treatment of BMMCs with DMS
markedly reduced degranulation induced by Fc RI cross-
linking (Fig. 4 A). There was a close correlation between
the dose-dependent inhibition of degranulation by DMS
(IC50   5  M; unpublished data) and the known Ki for in-
hibition of SphK1 and SphK2 of 4 and 12  M, respectively
(12, 18). Moreover, in agreement with its inability to inter-
fere with binding of S1P to its receptors (27), DMS did not
significantly affect degranulation induced by exogenous
S1P (Fig. 4 A).
Figure 4. Role of S1P formation in degranulation of mast cells. (A and
B) BMMCs were treated with vehicle, S1P, or anti-DNP IgE and DNP-
HSA (IgE/Ag), and hexosaminidase release was determined. Where indi-
cated, cells were pretreated with 10  M  N,N-dimethylsphingosine
(DMS) or 10  M d,l-threo-dihydrosphingosine (DHS) for 20 min or
with 200 ng/ml pertussis toxin (PTX) for 2 h before stimulation. Data are
expressed as percent of the total cellular amount after subtraction of spon-
taneous release, which was always  5%, and are means   SD. *, P   0.05
and **, P   0.01 by Student’s t test. NS, not significant. (C and D) S1P2
deficiency markedly reduces mast cell degranulation. (C) IgE-sensitized
wild-type BMMCs (white bars) and S1P2
 /  BMMC (black bars) were
stimulated for 20 min with 10 and 30 ng/ml Ag or ATP (1 mM), and
degranulation was determined as percentage of total hexosaminidase.
(D) IgE-sensitized wild type (open symbols) and S1P2
 /  (closed symbols)
BMMCs were stimulated with 30 ng/ml Ag for the indicated times, and
degranulation was determined. *, P   0.05 by Student’s t test. #, P   0.05
by ANOVA. NS, not significant.Jolly et al. 965
These results suggest that S1P produced by Fc RI trig-
gering could play a role in mast cell activation by binding
to its receptors, S1P1 or S1P2, present on mast cells. Be-
cause S1P1 is coupled solely to Gi (6), cells were pre-
treated with PTX to inactivate Gi. The inhibitory effect
of PTX was lower than the inhibitory effects of DMS
or d,l-threo-dihydrosphingosine, another SphK inhibitor
(Fig. 4 B).
Because the other mast cell S1P receptor, S1P2, can
couple to many G proteins, next we examined degranula-
tion responses in BMMCs derived from S1P2
    mice,
which develop normally. We found that degranulation in
these cells was significantly impaired when compared with
wild-type BMMCs in response to Fc RI cross-linking
(Fig. 4, C and D). The dramatic reduction of almost 50%
was observed at several concentrations of Ag. This defect
is not a reflection of a developmental defect in maturation
of the secretory compartment because total granule con-
tent and kinetics of degranulation (Fig. 4 D) were the same
as in wild-type cells. However, we noted that degranula-
tion induced by ATP was also significantly reduced in
S1P2 null BMMCs (Fig. 4 C). This might reflect the possi-
ble need to transactivate S1P2 by purinergic receptors. Al-
ternatively, the loss of S1P2 during development might al-
ter expression of signaling proteins that contribute to mast
cell degranulation.
To confirm and extend the involvement of SphK1 and
S1P and its receptors in degranulation, similar experiments
were performed with RBL-2H3 cells. DMS, at a concen-
tration that effectively inhibited SphK1 and S1P production,
markedly blocked hexosaminidase release in IgE-sensitized
RBL-2H3 cells, but did not affect ionomycin-induced de-
granulation (Fig. 5 A). We also used a molecular approach
to decrease SphK1 expression in fully developed cells by
siRNA targeted to SphK1. siSphK1 not only markedly
reduced SphK1 mRNA and protein (Fig. 5 B), it blocked
IgE-stimulated SphK activity (Fig. 5 C), supporting the
conclusion that SphK1 is the isoenzyme activated by IgE.
In agreement with the SphK inhibitor results, transfection
of RBL-2H3 cells with siSphK1 markedly inhibited Ag-
induced degranulation of RBL-2H3 cells (Fig. 5 D),
whereas transfection with control siRNA had no effect,
and siRNA targeted to SphK2 slightly increased degranu-
lation. In agreement with the lack of effect of DMS on
degranulation induced by calcium ionophore, siSphK1
did not influence ionomycin-induced degranulation (Fig.
5 D).
To further confirm the role of S1PRs in IgE-induced
degranulation, S1P1 and S1P2 expression in RBL-2H3
cells was down-regulated with specific antisense RNA
(Fig. 5 F), similar to previous analyses in other cell types
(15, 16). Antisense, but not sense, oligonucleotides for
Figure 5. Role of SphKs and
S1PRs in antigen-induced de-
granulation of RBL-2H3 cells.
(A) RBL-2H3 cells were stimu-
lated with IgE/Ag or ionomycin
(1  M) for 30 min in the absence
or presence of pretreatment with
10  M DMS, and hexosaminidase
release was determined. *, P  
0.01 by Student’s t test. NS, not
significant. (B–D) RBL-2H3 cells
were treated with control siRNA
or siRNAs specific to SphK1 or
SphK2 for 48 h. Cells were
lysed, and mRNA and proteins
were analyzed by RT-PCR or
Western blotting (WB) with
SphK-specific antibodies as de-
scribed in Supplemental Materials
and Methods. (C) SphK activity
was measured in membrane frac-
tions of IgE-sensitized RBL-2H3
cells after stimulation with Ag for
2 min. (D) In duplicate cultures,
degranulation by IgE/Ag (white
bars) or ionomycin (diagonally
striped bars) was measured. Data
are expressed as percent inhibition
of degranulation relative to control
siRNA. (E and F) RBL-2H3
cells were transfected with S1P1
or S1P2 antisense (as), sense (s),
or scrambled (scr) oligonucleotides
for 48 h and stimulated with
IgE/Ag or ionomycin for 60 min, and degranulation was measured. Data are expressed as percent inhibition of degranulation relative to scrambled controls.
(F) Representative Western blots showing reduction of S1P1 and S1P2 protein expression by antisense oligonucleotides as determined with specific antibodies
are shown. Blots were stripped and probed with antitubulin to show equal loading. *, P   0.05 by Student’s t test. NS, not significant.Transactivation of Mast Cell S1PRs by Fc RI 966
S1P2 specifically inhibited IgE-induced degranulation, but
did not affect ionomycin-induced degranulation (Fig. 5
E). In contrast, neither sense nor antisense S1P1 had any
effect on hexosaminidase release induced by IgE cross-
linking (Fig. 5 E), suggesting that S1P2 and not S1P1 is in-
volved in degranulation.
SphK and S1P1 Are Required for Migration of Mast Cells to-
ward Ag. Although it has long been appreciated that
asthmatics have more mast cells in their pulmonary tissue
than nonasthmatics, how these mast cells arrive at inflam-
matory sites in the lung is not known. Given that IgE trig-
gering can transactivate S1PRs, and S1PRs are known to
regulate cell movement (6), next we examined their roles
in motility of mast cells. A recent paper suggested that Ag
is not only a stimulant of allergic mediators release by IgE-
sensitized MC-9 mast cells, it is also a chemotactic factor
(28). In agreement, RBL-2H3 cells also migrated toward
Ag in a concentration-dependent manner (Fig. 6 A). In-
terestingly, not only was chemotaxis toward S1P blocked
by PTX, Ag-induced migration was completely inhibited
by PTX (Fig. 6 A), suggesting the involvement of a Gi-
mediated signaling pathway in migration of mast cells
toward Ag. In concordance, down-regulation of S1P1,
which is coupled solely to Gi, abrogated migration toward
Ag (Fig. 6 B), although it did not affect Ag-induced de-
granulation (Fig. 5 E). This was not a general effect on
motility because migration toward fibronectin was not af-
fected (Fig. 6 B). Moreover, overexpression of S1P1 in-
creased random motility or chemokinesis, probably due to
constitutive activation of S1P1 receptors as has been found
for many GPCRs (20). Nevertheless, overexpression of
S1P1 significantly enhanced chemotaxis toward both S1P
and Ag (Fig. 6 C). In contrast to S1P1, the other S1P re-
ceptor expressed on mast cells, S1P2, is a repellant recep-
tor that inhibits migration in diverse cell types (29). Simi-
larly, overexpression of S1P2 in mast cells significantly
impaired migration toward S1P and Ag, but not fibronec-
tin (Fig. 6 C).
Next, we examined the involvement of SphK1 in Ag-
directed motility. Treatment of RBL 2H3 cells with the
SphK inhibitor DMS blocked chemotaxis toward Ag at op-
timal and even higher concentrations of Ag (Fig. 6 D),
without affecting S1P-induced chemotaxis (Fig. 6 D). In
agreement, down-regulation of SphK1 expression com-
pletely blocked chemotaxis of RBL-2H3 cells toward
Ag (Fig. 6 E), whereas transfection with control siRNA
or siSphK2 had no effect. Importantly, SphK1-targeted
siRNA did not inhibit chemotaxis toward S1P or fibronec-
tin (Fig. 6 E). These results confirm that chemotaxis of
mast cells toward Ag requires Fc RI-triggered activation of
SphK1 and formation of S1P, which in turn activates S1P1
and downstream signals important for motility.
Figure 6. Chemotaxis of mast
cells toward Ag is dependent on
SphK1, Gi, and S1P1. (A) RBL-
2H3 cells were sensitized with
1  g/ml anti-DNP IgE in the
absence (white bars) or presence
of 200 ng/ml pertussis toxin
(PTX, black bars) and allowed to
migrate toward the indicated
concentrations of Ag or S1P (1
nM) for 3 h. (B) RBL-2H3 cells
were transfected with S1P1 anti-
sense (diagonally striped bars) or
scrambled oligonucleotides (white
bars) for 48 h, sensitized with
anti-DNP IgE, and allowed to
migrate toward 10 nM S1P, 10
ng/ml Ag, or 20  g/ml fibronec-
tin. (C) RBL-2H3 cells stably ex-
pressing  GFP-S1P1 (black bars)
or GFP-vector (white bars) were
sensitized with anti-DNP IgE
and allowed to migrate for 1.5 h
toward 10 nM S1P, 10 ng/ml
Ag, or 20  g/ml fibronectin.
Random motilities of vector and
S1P1 transfectants were 82   11
and 219   6, respectively. RBL-
2H3 cells stably expressing GFP-
S1P2 (gray bars) or GFP-vector
(white bars) were allowed to migrate toward the same agents for 3 h. Random motilities of vector and S1P2 transfectants were 157   9 and 174   29,
respectively. (inset) Western blot of cell lysates showing expression of GFP-S1P1 and GFP-S1P2 visualized by ECL with anti-GFP. Lanes 1, 2, and 3 are
lysates of cells overexpressing GFP vector, GFP-S1P1, and GFP-S1P2, respectively. (D) IgE-sensitized RBL-2H3 cells were treated without (white bars)
or with 1  M DMS (black bars) for 20 min before the addition of the indicated concentrations of Ag or S1P. (E) RBL-2H3 cells were transfected with
control siRNA (white bars), siRNA targeted to SphK1 (black bars), or siRNA targeted to SphK2 (gray bars) as described in Materials and Methods,
sensitized with 1  g/ml anti-DNP IgE for 6 h, and allowed to migrate toward vehicle (None), 10 ng/ml Ag, 10 nM S1P, or 20  g/ml fibronectin
for 3 h. Results are expressed as means   SD. *, P   0.05 by Student’s t test. #, P   0.05 by ANOVA.Jolly et al. 967
Discussion
In RBL-2H3 mast cells, Fc RI cross-linking stimulates
SphK to generate S1P, which has been proposed to func-
tion intracellularly independent of InsP3 to mobilize cal-
cium (2), a crucial event for mast cell function. In agree-
ment, down-regulation of SphK1 expression demonstrated
that IgE/Ag stimulation of SphK1 mediated fast and tran-
sient calcium release from intracellular stores in human
BMMCs (5). In contrast, PLC 1 induced a second slower
wave of calcium release from intracellular stores leading to
calcium influx (5). Interestingly, calcium responses in mast
cells induced by S1P are sensitive to PTX and, therefore,
mediated by a Gi-coupled receptor (3), whereas in contrast,
Fc RI-dependent calcium release is clearly PTX insensitive
(3, 30). It has also been suggested that the decisive balance
between sphingosine, the substrate for SphK, and S1P de-
termines the allergic responsiveness of mast cells (4, 31).
Although sphingosine acts as a potent inhibitor of IgE-trig-
gered leukotriene synthesis and cytokine production, S1P
counteracts the inhibitory effects of sphingosine (4). More-
over, sphingosine blocks the store-operated calcium re-
lease–activated calcium current (ICRAC) in RBL-2H3
cells (32). Hence, it was suggested that in the resting state,
sphingosine could act as a blocker of ICRAC and upon de-
pletion of internal stores, conversion of sphingosine to S1P
catalyzed by SphK lowers sphingosine levels and would
lead to dysinhibition of ICRAC (32).
A shortcoming of all of the previous studies is that they
did not consider the possibility that S1P might also act by
binding to a specific cell surface receptor. Similar to a pre-
vious analysis with human BMMCs (5), we found that
Fc RI cross-linking stimulates and translocates SphK1 to
the plasma membrane of mast cells, but not the other iso-
form, SphK2. However, in contrast with the suggestion
that S1P formed by activation of SphK in mast cells acts in-
tracellularly (2, 5), our data indicate that this S1P also regu-
lates important mast cell functions in an autocrine manner
by binding to its receptors, S1P1 and S1P2, present on the
cell surface. Several lines of evidence support the notion
that Fc RI cross-linking transactivates these S1PRs. First,
S1P is secreted upon mast cell activation. Second, Fc RI
triggering induced activation and internalization of S1P1
and S1P2, a S1P-dependent process that was blocked by a
specific inhibitor of SphK. Third, inhibition of mast cell
SphK1 by pharmacological or molecular approaches drasti-
cally reduced their migration toward Ag. Moreover, PTX,
which inactivates Gi, also blocked Ag-directed motility as
well as mobility toward S1P, suggesting the involvement of
Gi-coupled S1P1. In agreement, down-regulation of S1P1
reduced migration toward Ag. Finally, deletion of s1p2 or
reduction of its expression severely impaired degranulation
induced by IgE/Ag.
Previously, we have suggested a similar mechanism for
crosstalk between the tyrosine kinase receptor PDGFR and
S1PRs such as S1P1 (16). However, others have questioned
the generality of this concept (33). For example, the tyro-
sine kinase receptor for IGF-1 activates S1P1 by Akt-depen-
dent phosphorylation in a manner that does not require the
SphK pathway (34). In another example, PDGFR and S1P1
were shown to form a complex that was cointernalized by
PDGF as a functional signaling unit to regulate the ERK1/2
pathway (35). The results of these studies suggest ligand-in-
dependent activation of S1P1 and imply that activation of
SphK1 and intracellular generation of S1P are not important
for receptor crosstalk. In contrast, our data obtained after
cross-linking of the IgE receptor strongly support the partic-
ipation of SphK1 and formation of S1P, which in turn, in
an autocrine and/or paracrine fashion, stimulates S1P1 or
S1P2, leading to amplification of downstream signals impor-
tant for mast cell activation, particularly those related to
movement or degranulation. There are some precedents for
similar mast cell autocrine amplification loops. For example,
the release of preformed mast cell–associated TNF-  acts as
a positive autocrine feedback signal to augment nuclear fac-
tor  B activation and production of further cytokines, in-
cluding GM-CSF and IL-8 (36). In addition, human mast
cells express the enzymes that catalyze the committed step
in the biosynthesis of cysteinyl leukotrienes and their cog-
nate receptors, suggesting that these lipid mediators may be
involved in autocrine signaling pathways regulating mast
cell functions (37). Indeed, a recent paper demonstrates an
autocrine amplification mechanism via the cysteinyl-leuko-
triene receptor for production of IL-5 and TNF-  in re-
sponse to IgE receptor cross-linking (38).
Although it is well known that asthmatics have higher
numbers of mast cells in their pulmonary mucosa (1), it is
not clear how mast cells arrive at these sites. It was found
previously that migration of MC9 mast cells toward antigen
did not require polypeptide chemotactic factors produced
by the cells themselves (28). Our observations that Fc RI
triggering induced RBL-2H3 cells to produce and secrete
S1P, as well as the exquisite ability of mast cells to migrate
toward vanishingly small concentrations of S1P (1 nM),
prompted us to examine the involvement of S1PRs in anti-
gen-induced chemotaxis of mast cells. The fact that PTX
completely blocked migration not only toward S1P but
also toward Ag implicated a Gi-mediated pathway and sug-
gested that activation of S1P1 might be critical for Ag-
induced chemotaxis. If so, inhibition of SphK1, which pre-
vents formation of S1P and activation of its receptors,
should block migration of mast cells toward Ag. Indeed,
inhibition of SphK1 in mast cells by specific inhibitors or
siRNA drastically reduced chemotaxis toward Ag. In sharp
contrast, motility toward S1P was not affected, demonstrat-
ing that the loss of S1P formation was the cause of de-
creased migration toward Ag.
Of particular interest, significant mast cell migration to-
ward Ag was observed at 1 ng/ml, a concentration that was
much lower than that required for optimal Fc RI-trig-
gered degranulation (100 ng/ml). Thus, a compelling in
vivo scenario is that a gradient of antigen attracts mast cells.
When they reach areas of higher Ag concentration, this
causes them to stop moving and induces them to releaseTransactivation of Mast Cell S1PRs by Fc RI 968
their contents. Our finding that Fc RI cross-linking in-
creased S1P2 expression, which we showed inhibited mi-
gration of RBL-2H3 cells toward both S1P and Ag when
overexpressed, is consistent with this hypothesis. Thus, the
dynamic balance between S1P1 and S1P2 expression and
signaling after their transactivation by Fc RI cross-linking
could regulate mast cell migration toward antigen. Further-
more, antagonistic actions of S1P1 and S1P2 on cell move-
ment have been previously correlated with their opposing
effects on activation of the small GTPases Rho and Rac,
important for cell motility. Although S1P1 stimulated Rac-
coupled cortical actin formation (16, 34) and cell migra-
tion, activation of S1P2 elicited Rho-coupled stress fiber
assembly as well as negatively regulating Rac activity (39),
thereby inhibiting cell migration.
The net effects of S1P are determined by both the ex-
pression profile of the various S1P receptors and by the ac-
tivity of the intracellular pathways to which they are cou-
pled. We envision that this contributes to the ability of
mast cells to modulate their responses in both a temporal
and spatial manner. The studies reported here provide the
basis for a model whereby an S1P autocrine loop activating
opposing signaling of S1P1 and S1P2 might orchestrate re-
cruitment of mast cells to sites of inflammation. Moreover,
early in an inflammatory process, S1P produced by mast
cells can lead to heightened production of chemokines,
necessary for the recruitment of inflammatory cells such as
monocytes and eosinophils. We have shown previously
that weak stimulation of mast cells with Ag preferentially
elicited chemokines (13) and, thus, it is of interest whether
this response to Ag is mediated by S1P production. Altered
expression or activity of the various S1P receptors on the
mast cells, with a shift from G i-coupled S1P1 to G q- and
G 12/13-linked S1P2 would be reversed upon restoration of
homeostasis as the inflammation is resolved.
Mast cell degranulation is dependent on increased in-
tracellular calcium, activation of protein kinase C, and
changes in the actin cytoskeleton regulated by Rho family
GTPases (40). Interestingly, deletion of S1P2, which has
been linked to all of these signaling pathways, significantly
decreased degranulation of mast cells induced by IgE/Ag.
In contrast to BMMCs from Vav knockout mice, where
decreased hexosaminidase release resulted from slower ki-
netics (41), the kinetics of hexosaminidase release were
similar in wild type and S1P2 null BMMCs, though the ex-
tent of release was lower in the latter. These results imply
that transactivation of S1P2 may play an important role
downstream of Fc RI in mast cell degranulation.
Together with the previous observation that S1P levels
were significantly elevated in the asthmatic lung after chal-
lenge with an allergen (8), S1P and its receptors have the
ability to augment the allergic response on a broad scale not
only in mast cell activation as shown by our results but also
in activation of airway smooth muscle cells (8, 42), mono-
cytes (43), neutrophils (44), and endothelial cells (14, 15,
45), as well as by enhancing lymphocyte infiltration (46).
Thus, this paper highlights new potential therapeutic direc-
tions for treatment of asthma and other inflammatory disor-
ders aimed at decreasing S1P production or antagonizing
the actions of specific S1P receptors.
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